The value of cartilage biomarkers in progressive knee osteoarthritis: Cross-sectional and 6-year follow-up study in middle-aged subjects

Rheumatology International

Volumn 33, Issue 4, 2013, Pages 903-911

  Kumm, Jaanika ^a   Tamm, Ann ^a   Lintrop, Mare ^a   Tamm, Agu ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Cartilage biomarkers; Knee; Osteoarthritis; Osteophyte; Radiographic progression

Indexed keywords

BIOLOGICAL MARKER; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE II C TELOPEPTIDE FRAGMENT; PROCOLLAGEN TYPE II A AMINO TERMINAL PROPEPTIDE; UNCLASSIFIED DRUG; CARTILAGE MATRIX PROTEIN; COLLAGEN TYPE 2; GLYCOPROTEIN; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE I N TERMINAL PEPTIDE; PROCOLLAGEN TYPE I N-TERMINAL PEPTIDE; SCLEROPROTEIN;

ADULT; ARTICLE; BONE TURNOVER; CARTILAGE; CARTILAGE DEGENERATION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; FEMUR; FOLLOW UP; HUMAN; JOINT CAVITY; KNEE OSTEOARTHRITIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OSTEOPHYTE; OSTEOPHYTOSIS; PATELLA; PREDICTIVE VALUE; PRIORITY JOURNAL; TIBIA; ARTICULAR CARTILAGE; KNEE; LONGITUDINAL STUDY; METABOLISM; PROGNOSIS; RADIOGRAPHY; URINE;

ADULT; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; COLLAGEN TYPE II; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; KNEE JOINT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROGNOSIS;

EID: 84886606024     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2463-8     Document Type: Article

References (38)

1. Felson DT (2009) Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 11(1):203
2. Brandt KD, Doherty M, Lohmander LS (2003) Introduction: the concept of osteoarthritis as failure of the diarthrodial joint. In: Brandt KD, Doherty M, Lohmander LS (eds) Osteoarthritis. Oxford University Press, New York, pp 69-71
3. Senior K (2000) Osteoarthritis research: on the verge of a revolution? Lancet 355(9199): 208
4. Golightly YM, Marshall SW, Kraus VB, Renner JB, Villaveces A, Casteel C et al (2011) Biomarkers of incident radiographic knee osteoarthritis. Arthritis Rheum 63(8): 2276-2283
5. Kraus VB (2011) Osteoarthritis year 2010 in review: biochemical markers. Osteoarthritis Cartilage 19: 346-353
6. Ornetti P, Brandt K, Hellio-Le Graverand M-P, Hochberg M, Hunter DJ, Kloppenburg M et al (2009) OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthritis Cartilage 17(7): 856-863
7. Eckstein F, Le Graverand MP, Charles HC, Hunter DJ, Kraus VB, Sunyer T et al (2011) Clinical, radiographic, molecular and MRI-based predictors of cartilage loss in knee osteoarthritis. Ann Rheum Dis 70(7): 1223-1230
8. Conaghan PG, Hunter DJ, Maillefert JF, Reichmann WM, Losina E (2011) Summary and recommendations of the OARSI FDA osteoarthritis assessment of structural change working group. Osteoarthritis Cartilage 19: 606-610
9. Spector TD, Hart DJ, Byrne J, Harris PA, Dacre JE, Doyle DV (1993) Definition of osteoarthritis of the knee for epidemiological studies. Ann Rheum Dis 52: 790-794
10. Bettica P, Cline G, Hart DJ, Meyer J, Spector TD (2002) Evidence for increased bone resorption in patients with progressive knee osteoarthritis. Arthritis Rheum 46(12): 3178-3184
11. Ding C, Garnero P, Cicuttini F, Scott F, Cooley H, Jones G (2005) Knee cartilage defects: association with early radiographic osteoarthritis, decreased cartilage volume, increased joint surface area and type II collagen breakdown. Osteoarthritis Cartilage 13: 198-205
12. Kumm J, Tamm AE, Lintrop M, Tamm AO (2011) The prevalence and progression of radiographic knee osteoarthritis over 6 years in a population-based cohort of middle-aged subjects. Rheum Int. doi:10.1007/s00296-011-2221-3
13. Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S (2004) Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum 50: 2479-2488
14. Sharif M, Kirwan J, Charni N, Sandell LJ, Whittles C, Garnero P (2007) A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis - associations with disease progression. Rheumatology 46: 938-943
15. van Spil WE, DeGroot J, Lems WF, Oostveen JC, Lafeber FP (2010) Serum and urinary biochemical markers for knee and hiposteoarthritis: a systemic review applying the consensus BIPED criteria. Osteoarthritis Cartilage 18: 605-612
16. Sharif M, Saxne T, Shepstone L, Kirwan JR, Elson CJ, Heinegard D et al (1995) Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 34: 306-310
17. Vilim V, Olejarova M, Machacek S, Gatterova J, Kraus VB, Pavelka K (2002) Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthritis Cartilage 10: 707-713
18. Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H et al (2006) Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 65: 1050-1054
19. Hunter DJ, Li J, LaValley M, Bauer DC, Nevitt M, DeGroot J et al (2007) Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee study. Arthritis Res Ther 9(5):R108
20. Sowers MF, Karvonen-Gutierrez CA, Yosef M, Jannausch M, Jiang Y, Garnero P et al (2009) Longitudinal changes of serum COMP and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. Osteoarthritis Cartilage 17: 1609-1614
21. Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C (2009) Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI. Osteoarthritis Cartilage 17: 384-389
22. Garnero P, Ayral X, Rousseau J-C, Christgau S, Sandell LJ, Dougados M et al (2002) Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 10:2613- 2624
23. Bruyere O, Collette J, Kothari M, Zaim S, White D, Genant H et al (2006) Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 65: 1050-1054
24. Cibere J, Zhang H, Garnero P, Poole AR, Lobanok T, Saxne T et al (2009) Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum 60: 1372-1380
25. Schouten JS, Van den Ouweland FA, Valkenburg HA, Lamberts SW (1993) Insulin-like growth factor-1: a prognostic factor of knee osteoarthritis. Br J Rheumatol 32: 274-280
26. Petersson IF, Boegard T, Svensson B, Heinegard D, Saxne T (1998) Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 37: 46-50
27. Sugiyama S, Itokazu M, Suzuki Y, Shimizu K (2003) Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis. Ann Rheum Dis 62: 27-32
28. Tamm A, Lintrop M, Veske K, Hansen U, Tamm A (2008) Prevalence of patello- and tibiofemoral osteoarthritis in Elva, Southern Estonia. J Rheumatol 35: 543-544
29. Boegard T, Rudling O, Petersson IF, Sanfridsson J, Saxne T, Svensson B et al (1998) Joint-space width in the axial view of the patello-femoral joint. Definitions and comparison with MR imaging. Acta Radiol 39: 24-31
30. Nagaosa Y, Mateus M, Hassan B, Lanyon B, Doherty M (2000) Development of logically devised line drawing atlas for grading of knee osteoarthritis. Ann Rheum Dis 59: 587-595
31. Botha-Scheepers S, Watt I, Breedveld FC, Kloppenburg M (2005) Reading radiographs in pairs or in chronological order influences radiological progression in osteoarthritis. Rheumatology 44: 1452-1455
32. Hashimoto S, Creighton-Achermann L, Takahashi K, Amiel D, Coutts RD, Lotz M (2002) Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage 10: 180-187
33. Blaney Davidson EN, Vitters EL, van Beuningen HM, van de Loo FAJ, van den Berg WB, van der Kraan PM (2007) Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum 56: 4065-4073
34. Gelse K, Söder S, Eger W, Diemtar T, Aigner T (2003) Osteophyte development - molecular characterization of differentiation stages. Osteoarthritis Cartilage 11: 141-148
35. Kumm J, Tamm AE, Veske K, Lintrop M, Tamm AO (2006) Associations between cartilage oligomeric matrix protein and several articular tissues in early knee joint osteoarthritis. Rheumatology 45: 1308-1309
36. Kumm J, Tamm AE, Lintrop M, Tamm AO (2009) Associations between ultrasonographic findings and bone/cartilage biomarkers in patients with early-stage knee osteoarthritis. Calcif Tissue Int 85: 514-522
37. Di Cesare PE, Fang C, Leslie MP, Tulli H, Perris R, Carlson CS (2000) Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts. J Orthop Res 18: 713-720
38. Boegard T, Rudling O, Petersson IF, Jonsson K (1998) Correlation between radiographically diagnosed osteophytes and magnetic resonance detected cartilage defects in the tibiofemoral joint. Ann Rheum Dis 57: 401-407